JENNIFER KRUSHINSKI: Open Payments
NPI 1225212079 · CATONSVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$290 in 13 payments from 5 companies in 2025. Trend: 2023 $692 · 2024 $605 · 2025 $290
Food & beverage: $290
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $110 |
| ABBVIE INC. | 5 | $85 |
| LEO Pharma Inc. | 2 | $49 |
| Amgen Inc. | 1 | $28 |
| Incyte Corporation | 1 | $20 |
Products named: SKYRIZI, Rhapsido, ADBRY, OTEZLA, RINVOQ, OPZELURA.
Industry payments across MD — which companies pay providers there.
